Some 14,000 patients in the Netherlands participated in the study, having been diagnosed with gastrointestinal cancer from 1998 until 2011. Those of them who took aspirin subsequently had a “significant” survival benefit: in the four-year follow-up period, those who took aspirin were two twice as likely to be alive. Trial co-ordinator Dr Martine Frouws, from […]